Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases

 
This item is provided by the institution :

Repository :
Annals of Gastroenterology
see the original item page
in the repository's web site and access all digital files if the item*
share



Semantic enrichment by EKT
Journal part (EN)
Scientific article (EN)
Article (EN)
2014 (EN)
Vedolizumab, a gut-specific monoclonal antibody, renews hope for an alternative to anti-TNF therapy in inflammatory bowel diseases (EN)
Rezaie, Ali
info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
Hellenic Society of Gastroenterology
Annals of Gastroenterology
Clinical Opinions
English
2014-03-11
http://www.annalsgastro.gr/index.php/annalsgastro/article/view/1619
Hellenic Society of Gastroenterology (EN)
1792-7463
1108-7471
Annals of Gastroenterology; Volume 27, No 2 (2014); 179 (EN)



*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)